| Metric | Details |
|---|---|
| Parent / Legal Entity | NextCare Holdings (parent operating entity) |
| S&P / Moody‑s / Fitch | Not rated (private company, no public debt) |
| Investment Grade Status | Not Rated — Private Equity-Backed Multi-State Chain |
| Sector | Healthcare — Mid-Market Metro Urgent Care |
| Ownership | Private — Enhanced Healthcare Partners + management (PE-backed since 2021) |
| US Location Count | ~170 clinics across 10 states |
| Geographic Concentration | AZ, CO, KS, MI, NY, NC, OK, TX, VA, LA — mid-market metro focus |
| Cap Rate Range | 6.50% – 7.75% |
| Typical Lease Term Remaining | 8 – 14 years on new builds; 5 – 10 years on mid-lease product |
| Guarantee Type | Corporate (NextCare Holdings parent) or operating subsidiary |
| Typical Building Size | 3,000 – 5,000 SF (freestanding) or inline |
| Typical Price Range | $1.4M – $3.2M |
NextCare Urgent Care Business Overview & NNN Investment Profile
NextCare Urgent Care is one of the largest multi-state private-equity-backed urgent care chains in the United States, operating approximately 170 clinics across 10 states as of Q1 2026. Unlike Fast Pace Urgent Care, which is deliberately focused on rural and small-town southeastern markets, NextCare’s network concentrates in mid-market metros including Phoenix, Denver, Colorado Springs, Dallas, Raleigh, Charlotte, Wichita, Detroit, Tulsa, and the New York suburbs. This metro-focused positioning places NextCare in direct competition with hospital-affiliated urgent care networks and other PE-backed chains, requiring stronger unit-level operating discipline and marketing to defend share.
For NNN investors, NextCare sits in the same non-rated PE-backed urgent care category as Fast Pace but with a distinctly different geographic and competitive profile. The company was founded in 1993 and operates under Enhanced Healthcare Partners’ ownership since 2021. Enhanced is a middle-market healthcare-focused PE firm with a multi-billion-dollar fund platform and a sector specialization that provides better continuity than generalist PE ownership. Cross-reference against the tenant credit ratings database to see how non-rated urgent care operators price against the full healthcare NNN credit spectrum.
NextCare Credit Rating Analysis
NextCare Urgent Care carries no public credit rating from S&P Global Ratings, Moody’s Investors Service, or Fitch Ratings. This is standard for privately-held, PE-backed urgent care chains — none of the major private-equity-owned urgent care operators (NextCare, Fast Pace, MedPost, WellNow, CityMD/Summit Health) carry traditional public credit ratings. NNN investors should price NextCare leases as non-rated, PE-backed operator credit with specific attention to sponsor quality, the company’s operating trajectory, and property-specific factors including trade-area demographics and competitive density.
The primary credit considerations for NNN investors underwriting a NextCare property are: competitive density in the metro markets NextCare occupies (Phoenix, Dallas, Denver, and Raleigh all have multiple competing urgent care chains plus hospital-affiliated networks), the operating dependence on commercial payer reimbursement and payer mix, and the absence of public financial disclosure that would allow direct rent coverage analysis. Offsetting these considerations: the metro mid-market focus provides access to commercial payer mix superior to rural markets, the 30+ year operating history predates most PE-backed urgent care peers, and the Enhanced sponsor’s healthcare specialization provides operational credibility.
NextCare NNN Lease Structure
NextCare NNN leases typically feature 10–15 year initial terms on new construction, with two to three 5-year renewal options, true NNN lease language (tenant pays taxes, insurance, routine maintenance), and rent escalations of 2% annually or 10% every 5 years. Mid-lease product (acquired through secondary market NNN brokerage) typically has 5–10 years remaining. The corporate guarantee is signed by NextCare’s parent operating entity; verify the specific guarantor in every transaction and, for larger-dollar purchases, request the most recent audited or reviewed financial statements under NDA.
The clinic format is typically a 3,000 to 5,000 SF freestanding or inline building in a suburban or mid-market metro retail corridor, often on a pad site in a grocery-anchored center or a repurposed standalone retail box. The medical build-out includes exam rooms, a lab draw station, on-site x-ray, and specialized medical gas and HVAC infrastructure. Build-out costs typically run $200–$350 per SF depending on the TI allocation between landlord and tenant. Review the investment grade guide for the framework on evaluating non-rated PE-backed operator credit within NNN underwriting.
NextCare NNN Cap Rate & Pricing Trends
NextCare urgent care clinics trade at cap rates of 6.50% to 7.75% as of Q1 2026, slightly wider than Fast Pace’s 6.25%–7.50% range. The modest premium reflects the competitive-density factor in NextCare’s metro markets: a Fast Pace clinic in a rural Tennessee market with one competing hospital has more market moat than a NextCare clinic in Dallas or Phoenix where three or more urgent care networks operate within a 3-mile radius. Tightest pricing is on newly-constructed pad-site properties in strong demographic trade areas with 12+ year remaining terms; mid-lease product (5–10 years remaining) trades at 7.00% to 7.75%; and shorter-tail product (under 5 years) trades at 7.75%+ with pricing weighted toward residual medical office value.
Pricing typically ranges from $1.4 million to $3.2 million, reflecting the 3,000–5,000 SF format and the mid-market metro suburban context. The cap rate premium over IG healthcare operators like HCA, Fresenius, or UHS runs 100–175 bps, reflecting the non-rated credit profile and the narrower buyer pool for private-equity-backed operator credit. Cross-reference against the NNN cap rates 2026 report for the full cross-sector benchmark context and how metro urgent care prices against rural urgent care and IG healthcare MOB product.
NextCare Real Estate Footprint
NextCare’s approximately 170 clinics are concentrated in Arizona (the company’s largest market and historical home base, with the strongest clinic density in Phoenix, Tucson, and the Phoenix suburbs), Colorado (Denver metro, Colorado Springs), Texas (Dallas-Fort Worth, Austin, Houston suburbs), North Carolina (Raleigh-Durham, Charlotte), and the secondary state markets of Kansas (Wichita), Michigan (Detroit metro), New York (Long Island and Westchester suburbs), Oklahoma (Tulsa), Virginia, and Louisiana. This multi-state metro footprint provides geographic diversification that narrow-focus rural chains like Fast Pace do not offer but also exposes the network to metro competitive dynamics including hospital-system affiliate networks.
The clinic footprint has been relatively stable in unit count since the 2021 Enhanced acquisition, with growth emphasis on same-clinic operating leverage rather than rapid unit expansion. This contrasts with the aggressive unit growth pattern at Fast Pace (under Revelstoke Capital). For NNN landlords, the slower unit-growth profile means a more limited flow of new-build sale-leaseback NNN product from NextCare relative to Fast Pace, with secondary market NNN transactions forming a larger share of NextCare’s NNN real estate presence. Cross-reference against AFC Urgent Care, CityMD, and Fast Pace for comparable urgent care NNN tenant positioning.
NextCare Growth Strategy & Forward Outlook
NextCare’s forward growth strategy under Enhanced Healthcare Partners centers on three pillars: same-clinic operating margin expansion through technology upgrades and payer mix optimization, selective bolt-on acquisition of smaller regional urgent care chains in existing states, and modest de novo expansion in underpenetrated submarkets within the existing state network. This is a more measured growth profile than the aggressive unit-count expansion at Fast Pace, reflecting both the mid-hold period dynamic and the more competitive metro market context.
The primary forward risks flagged for non-rated PE-backed healthcare tenants include: reimbursement rate pressure on commercial and government payers, metro competitive density which can pressure clinic-level unit economics, potential sponsor exit or recapitalization within the next 2–3 years (Enhanced acquired in 2021, so 2026–2028 is a credible exit window), and payer mix shifts in trade areas where hospital-affiliate urgent care networks are expanding. For NNN landlords, the practical implication is that NextCare is a solid-operator credit tenant with reasonable base-term lease security, but the sponsor exit timeline dynamic warrants slightly tighter landlord-protective lease provisions and more careful single-market concentration analysis than would apply to an IG-rated hospital-system credit.
NextCare NNN Investment: Pros & Cons
| Pros | Cons |
|---|---|
| Geographic Diversification: 10-state mid-market metro footprint provides exposure to higher commercial payer mix than rural chains; less single-market concentration. | Non-Rated Credit: No public S&P/Moody’s/Fitch rating; credit underwriting relies on sponsor quality and operator disclosure rather than letter grades. |
| Healthcare-Specialist Sponsor: Enhanced Healthcare Partners specializes in middle-market healthcare with multi-billion-dollar platform; sector continuity through hold periods. | Sponsor Exit Window: Enhanced acquired 2021; 2026–2028 is a credible PE exit window that could alter operating strategy or recapitalization structure. |
| 30+ Year Operating History: Founded 1993; predates most PE-backed urgent care peers and provides multi-cycle operating track record. | Metro Competitive Density: Phoenix, Dallas, Denver, Raleigh have multiple competing urgent care networks plus hospital-system affiliates; share defense is active. |
| Check Size Fit: $1.4M–$3.2M price range aligns well with 1031 exchange, family office, and individual investor capital. | Limited New-Build Pipeline: Under Enhanced, NextCare has emphasized same-clinic margin expansion over rapid unit growth; less flow of new sale-leaseback NNN product than Fast Pace. |
Comparable NNN Tenants
| Tenant | Rating | Sector | Cap Rate Range |
|---|---|---|---|
| NextCare Urgent Care | Not Rated (PE-backed) | Metro Urgent Care | 6.50% – 7.75% |
| Fast Pace Health | Not Rated (PE-backed) | Rural Urgent Care | 6.25% – 7.50% |
| AFC Urgent Care | Not Rated (Franchise) | Urgent Care | 6.50% – 7.75% |
| CityMD / Summit Health | Not Rated (Village MD) | Urban Urgent Care | 6.00% – 7.25% |
| HCA Healthcare | BBB- / Baa3 | Hospital / MOB / ASC | 5.50% – 7.00% |
Frequently Asked Questions About NextCare Urgent Care NNN Investments
No. NextCare Holdings is privately held by Enhanced Healthcare Partners and carries no public credit rating from S&P Global Ratings, Moody’s Investors Service, or Fitch Ratings. This is standard for private-equity-owned urgent care chains. NNN investors should price NextCare leases as non-rated, PE-backed operator credit and underwrite using sponsor quality, operator trajectory, and property-specific factors including trade-area demographics and competitive density.
NextCare urgent care NNN properties trade at 6.50% to 7.75% cap rates as of Q1 2026, a modest 25 bps wider than Fast Pace’s rural southeastern footprint reflecting the metro competitive-density factor. Tightest pricing is on newly-constructed pad-site properties in strong demographic trade areas with 12+ year remaining terms. Mid-lease product (5–10 years remaining) trades at 7.00% to 7.75%.
Enhanced Healthcare Partners, a middle-market private equity firm specializing exclusively in healthcare services investments. Enhanced acquired NextCare in 2021 from previous PE sponsor Sterling Partners. As of 2026, NextCare is in the mid-hold period for Enhanced, with operating emphasis on same-clinic margin expansion and selective bolt-on acquisitions rather than rapid geographic expansion.
New construction NextCare leases typically run 10–15 year initial terms with two to three 5-year renewal options, true NNN language (tenant pays taxes, insurance, routine maintenance), and rent escalations of 2% annually or 10% every 5 years. Mid-lease product commonly offers 5–10 years remaining. Verify the specific guarantor entity: corporate parent NextCare Holdings guarantee is stronger than operating subsidiary guarantees.
NextCare operates approximately 170 clinics concentrated in Arizona (Phoenix, Tucson — the company’s historical home base), Colorado (Denver, Colorado Springs), Texas (Dallas-Fort Worth, Austin, Houston suburbs), and North Carolina (Raleigh-Durham, Charlotte), with secondary presence in Kansas (Wichita), Michigan (Detroit metro), New York (Long Island, Westchester), Oklahoma (Tulsa), Virginia, and Louisiana. The mid-market metro focus distinguishes NextCare from rural-focused chains like Fast Pace.
All three are non-rated private-equity-backed or franchise-system urgent care chains with similar NNN lease structures. NextCare focuses on mid-market metros with 170 clinics across 10 states; Fast Pace focuses on rural and small-town southeastern markets with 270 clinics; AFC operates a franchise model with approximately 400 locations nationwide. Cap rate ranges overlap heavily (6.25%–7.75%), with geographic and payer mix differences driving modest spread between the three. Holding all three across a multi-property NNN allocation provides diversification within the urgent care category.
Urgent care medical build-outs offer exceptional cost segregation potential. Specialty medical gas systems, OR-grade HVAC, clinical utilities, x-ray shielding, and highly specific interior build-outs can be reclassified from 39-year real property to 5-, 7-, or 15-year recovery periods at meaningfully higher ratios than generic retail. For NextCare’s PE-backed non-rated credit profile, front-loaded depreciation helps offset the cap rate premium inherent in non-rated healthcare product. See our full ranking of net lease sectors by depreciation value: Best NNN Tenants for Bonus Depreciation: The Complete Ranking.
The Only NextCare NNN Advisor Whose Fee Comes From the Deal, Not From You
In NNN buyer representation, the listing broker pays the cooperating commission. That means you get a dedicated urgent care NNN advisor handling sourcing, underwriting, financing, and closing — and on the majority of transactions, there is no separate fee to you as the buyer.
Here’s what that buys you on a metro urgent care acquisition:
Find It — On-market and off-market NextCare NNN properties sourced and underwritten on your behalf, with particular attention to the metro competitive density (how many competing urgent care networks operate within 3 miles), the trade-area commercial payer mix, the guarantor entity, and the lease structural terms. We know which Phoenix, Dallas, Denver, and Raleigh submarkets are pricing the PE-backed credit correctly, which listings are compressing cap rates too aggressively in contested metros, and where the underlying real estate fundamentals add residual medical-office value.
Fund It — Non-rated urgent care NNN is a specialized lending segment. Bank paper, specialty healthcare real estate lenders, and select life companies compete in this space. We maintain 150+ lender relationships including the specific healthcare-real-estate desks that consistently underwrite PE-backed urgent care at reasonable LTV and rate terms with specific attention to the metro competitive density factor.
Exit It — Selling a NextCare asset ahead of a potential sponsor exit, repositioning through a 1031, or running a portfolio aggregation play? Our Capital Markets desk targets the private family offices, healthcare REITs, and passive investors actively acquiring small-box urgent care NNN — not a public blast that signals desperation.
Not committed to NextCare? Tell us your criteria — cap rate floor, credit tier, lease structure, geography, equity check size — and we’ll find the deal that fits. We represent investors across the full NNN credit spectrum. The tenant is a variable. Your criteria is the constant.
Get Your Free NextCare NNN Consultation →
In a 1031 exchange with a deadline? Tell us your timeline — we move faster.
Related NNN Tenants
Own a NextCare Property? Capital Markets Strategies Beyond Selling
Maturing debt and considering refinancing? Our capital markets team maintains 150+ lender relationships underwriting non-rated PE-backed urgent care across bank, specialty healthcare, and select life company desks. We structure rate-and-term refinancing, cash-out refis, and bridge-to-perm takeouts matched to the specific lease term, metro competitive density, and guarantor entity.
Evaluating a 1031 exchange or disposition? We represent both sides of NextCare NNN transactions — whether you are looking to exit ahead of a potential Enhanced sponsor exit in 2026–2028, exchange into IG healthcare or QSR product for stronger credit, or reposition through a sale-leaseback structure.
Building a metro urgent care NNN allocation? NextCare anchors the mid-market metro urgent care category. Off-market portfolio opportunities — 3 to 5 clinics across Phoenix, Dallas, or Raleigh, typically $7M–$15M total — trade at cap rate discounts of 25–50 bps to single-asset pricing.
Own multiple NextCare Urgent Care properties? Considering an off-market sale?
Investment Grade represents owners on confidential disposition of NextCare Urgent Care portfolios and individual properties through off-market direct-to-principal distribution to specialty REITs, private equity funds, and family offices. NextCare Urgent Care buyer demand runs deep, and portfolio sales consistently produce stronger pricing than sequential individual sales because the institutional buyer pool is structured around portfolio acquisition.
For multi-property owners considering a portfolio disposition, see Selling Investment Grade NNN Off-Market: Tenant-by-Tenant Buyer Demand. For the full off-market framework covering individual property dispositions, sale-leasebacks, and 1031 coordination, see Off-Market CRE Sales: The Complete 2026 Guide.
The pre-listing conversation is at no cost and fully confidential. Email team@investmentgrade.com or see contact Investment Grade.
